CS
LLY icon

Cannell & Spears’s Eli Lilly LLY Stock Holding History

Cannell & Spears’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.44M Sell
3,737
-23
-0.6% -$23.3K 0.07% 156
2025
Q4 		$4.04M Sell
3,760
-38
-1% -$36.3K 0.08% 150
2025
Q3 		$2.9M Sell
3,798
-144
-4% -$107K 0.05% 169
2025
Q2 		$3.07M Buy
3,942
+7
+0.2% +$5.44K 0.06% 168
2025
Q1 		$3.25M Buy
3,935
+8
+0.2% +$6.66K 0.07% 163
2024
Q4 		$3.03M Sell
3,927
-7
-0.2% -$5.8K 0.06% 162
2024
Q3 		$3.49M Buy
3,934
+734
+23% +$660K 0.07% 151
2024
Q2 		$2.9M Buy
3,200
+202
+7% +$162K 0.06% 153
2024
Q1 		$2.33M Buy
2,998
+752
+33% +$535K 0.05% 165
2023
Q4 		$1.31M Buy
2,246
+100
+5% +$58.4K 0.1% 80
2023
Q3 		$1.15M Hold
2,146
– – 0.1% 79
2023
Q2 		$1.01M Buy
2,146
+189
+10% +$79.3K 0.08% 96
2023
Q1 		$672K Hold
1,957
– – 0.06% 115
2022
Q4 		$716K Buy
1,957
+62
+3% +$22K 0.07% 102
2022
Q3 		$613K Hold
1,895
– – 0.06% 106
2022
Q2 		$614K Hold
1,895
– – 0.06% 115
2022
Q1 		$543K Hold
1,895
– – 0.04% 141
2021
Q4 		$523K Hold
1,895
– – 0.04% 146
2021
Q3 		$438K Hold
1,895
– – 0.03% 154
2021
Q2 		$435K Hold
1,895
– – 0.03% 158
2021
Q1 		$354K Sell
1,895
-600
-24% -$117K 0.03% 170
2020
Q4 		$421K Hold
2,495
– – 0.04% 148
2020
Q3 		$369K Hold
2,495
– – 0.04% 149
2020
Q2 		$410K Sell
2,495
-500
-17% -$76.8K 0.04% 133
2020
Q1 		$415K Sell
2,995
-714
-19% -$98.1K 0.05% 123
2019
Q4 		$487K Buy
3,709
+459
+14% +$53.2K 0.05% 109
2019
Q3 		$363K Hold
3,250
– – 0.04% 127
2019
Q2 		$360K Sell
3,250
-1,500
-32% -$177K 0.04% 123
2019
Q1 		$616K Hold
4,750
– – 0.08% 87
2018
Q4 		$550K Sell
4,750
-450
-9% -$50.3K 0.08% 87
2018
Q3 		$558K Hold
5,200
– – 0.07% 98
2018
Q2 		$444K Hold
5,200
– – 0.06% 108
2018
Q1 		$402K Hold
5,200
– – 0.05% 114
2017
Q4 		$439K Hold
5,200
– – 0.05% 115
2017
Q3 		$445K Hold
5,200
– – 0.05% 102
2017
Q2 		$428K Sell
5,200
-150
-3% -$12.2K 0.05% 92
2017
Q1 		$450K Sell
5,350
-250
-4% -$20K 0.06% 83
2016
Q4 		$412K Hold
5,600
– – 0.05% 90
2016
Q3 		$449K Sell
5,600
-750
-12% -$60K 0.06% 85
2016
Q2 		$500K Sell
6,350
-7,325
-54% -$551K 0.06% 75
2016
Q1 		$985K Buy
13,675
+7,325
+115% +$554K 0.12% 57
2015
Q4 		$535K Buy
6,350
+100
+2% +$8.3K 0.06% 81
2015
Q3 		$523K Hold
6,250
– – 0.06% 84
2015
Q2 		$522K Sell
6,250
-1,180
-16% -$89.9K 0.06% 95
2015
Q1 		$540K Sell
7,430
-1,900
-20% -$135K 0.06% 90
2014
Q4 		$644K Hold
9,330
– – 0.07% 86
2014
Q3 		$605K Sell
9,330
-550
-6% -$34.8K 0.07% 84
2014
Q2 		$614K Sell
9,880
-100
-1% -$5.97K 0.07% 82
2014
Q1 		$587K Buy
9,980
+1,200
+14% +$67K 0.07% 69
2013
Q4 		$448K Hold
8,780
– – 0.06% 75
2013
Q3 		$442K Buy
+8,780
New +$460K 0.06% 74

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cannell & Spears's LLY Position: Q1 2026 in Review

Cannell & Spears reduced its Eli Lilly (LLY) stake by 0.61% in Q1 2026, selling an estimated $23.3K and leaving 3,737 shares worth $3.44M. The position accounts for 0.07% of the portfolio, ranked #156.

Cannell & Spears first reported a position in LLY in Q3 2013 and has held it in 51 quarters since. The position peaked at $4.04M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cannell & Spears held 3,737 shares of Eli Lilly worth $3.44M as of Q1 2026.
  • Cannell & Spears sold 23 Eli Lilly shares in Q1 2026, an estimated $23.3K.
  • Eli Lilly made up 0.07% of Cannell & Spears's portfolio in Q1 2026, its #156 holding.
  • Cannell & Spears first reported a position in Eli Lilly in Q3 2013 and has held it in 51 quarters since.
  • Cannell & Spears's Eli Lilly position peaked at $4.04M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.